Detalles de la búsqueda
1.
A phase II study to evaluate lenalidomide in combination with metronomic-dose cyclophosphamide in patients with heavily pretreated classical Hodgkin lymphoma.
Acta Oncol
; 54(6): 933-8, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25734915
2.
Early use of tocilizumab in patients with severe pneumonia secondary to severe acute respiratory syndrome coronavirus 2 infection and poor prognostic criteria: Impact on mortality rate and intensive care unit admission.
Medicine (Baltimore)
; 100(29): e26533, 2021 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34398008
3.
Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer.
Oncology
; 79(1-2): 98-104, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21079407
4.
Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: a multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group.
Leuk Lymphoma
; 55(1): 51-5, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23573825
5.
Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years.
Leuk Lymphoma
; 60(3): 856-859, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30234403
6.
Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?
Clin Transl Oncol
; 14(5): 386-90, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22551546
7.
SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.
Clin Transl Oncol
; 12(11): 753-9, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20974568
Resultados
1 -
7
de 7
1
Próxima >
>>